Mangrove Partners Aslan Pharmaceuticals LTD Transaction History

Mangrove Partners

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.36 - $0.9 $699,296 - $1.75 Million	-1,942,491 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.74 - $1.22 $423,342 - $697,943	-572,085 Reduced 22.75%	1,942,491 $1.75 Million
Q2 2021 Aug 16, 2021	SELL	$2.5 - $3.72 $5.45 Million - $8.1 Million	-2,178,063 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.5 - $3.72 $6.29 Million - $9.35 Million	2,514,576 New	2,514,576 $8.3 Million
Q1 2021 May 17, 2021	BUY	$1.86 - $5.25 $4.05 Million - $11.4 Million	2,178,063 New	2,178,063 $7.3 Million

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Mangrove Partners, based on Form 13F filings with the SEC.

Stay updated on Mangrove Partners with notifications on news.